Current symptomatic pulmonary embolism
Prior or concurrent pulmonary embolism
Pulmonary embolism within  days prior to study entry
Pulmonary embolism
Symptomatic pulmonary embolism within  months prior to study entry
Any known uncontrolled cardiovascular disease, pulmonary embolism, hypertension not adequately controlled by standard medications within  months prior to enrollment.
Pulmonary embolism (PE) in the  months before enrollment; anticoagulation is permitted as long as stable dosage for more than  months
Pulmonary embolism.
ENTRECTINIB EXCLUSION CRITERIA: Pulmonary embolism in the  months prior to study drug administration
Subjects with a history of pulmonary embolism are excluded
Pulmonary embolism
Has a history of blood clots, pulmonary embolism, or DVT unless controlled by anticoagulant treatment
Patients with any prior history of arterial thrombosis or symptomatic pulmonary embolism
Pulmonary embolism
Previous history of pulmonary embolism or pulmonary embolism found on screening exam.
Any other serious cardiac illness or medical conditions such as unstable angina, pulmonary embolism, or uncontrolled hypertension.
Any other serious cardiac illness or medical conditions such as unstable angina, pulmonary embolism, or uncontrolled hypertension
Pulmonary embolism.
Pulmonary embolism within  months before screening
Pulmonary embolism on active therapy
History of arterial or venous embolism within  months prior to study enrollment. If the embolism occurred > and < months, the participant is eligible provided appropriate treatment according to institutional standard of care is ensured.
Previous history of pulmonary embolism or pulmonary embolism found on screening exam.
Previous pulmonary embolism within  months before study entry
Previous pulmonary embolism within  months prior to study entry
Pulmonary embolism (PE) within the last  months prior to registration
Diagnosis of acute pulmonary embolism within past  weeks
Participant has had pulmonary embolism or any other thrombo-embolic event within  months prior to study entry
Diagnosis of acute pulmonary embolism within past  weeks
acute pulmonary embolism or pulmonary infarction,
Participants with type  diabetes, documented stomach ulcers and pulmonary embolism
